GMAB logo

Genmab A/S (GMAB) Cash From Financing

Annual CFF

-$87.98 M
+$23.87 M+21.34%

December 31, 2023

Summary

Performance

1-Year Change

+21.34%

3-Year Change

-908.76%

5-Year Change

-682.29%

15-Year Change

-368.84%

GMAB Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.81%
GMAB annual cash flow from financing activities is higher than 8.81% of companies in Healthcare sector

High & Low

All-time High

$548.79 M
GMAB annual cash flow from financing activities is currently -116.03% below its historical high of $548.79 million

3-Year Low

-$111.85 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GMAB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 8, 2025
GMAB next annual earnings announcement is scheduled for May 8, 2025

OtherGMABcash flowmetrics:

Annual CFI

-$186.13 M
GMAB annual cash flow from investing activities is -$186.13 million

Annual CFO

$1.07 B
GMAB annual cash flow from operations is $1.07 billion

Annual FCF

$1.02 B
GMAB annual free cash flow is $1.02 billion

Annual CAPEX

$54.59 M
GMAB annual capital expenditures is $54.59 million

Quarterly CFF

-$51.71 M
+$387.90 M+88.24%

September 1, 2024

Summary

Performance

3-Month Change

+88.24%

1-Year Change

-1827.72%

3-Year Change

+41.31%

5-Year Change

+41.31%

GMAB Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.83%
GMAB quarterly cash flow from financing activities is higher than 6.83% of companies in Healthcare sector

High & Low

All-time High

$541.62 M
GMAB quarterly cash flow from financing activities is currently -109.55% below its historical high of $541.62 million

3-Year Low

-$439.61 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABcash flowmetrics:

Quarterly CFI

$2.09 M
GMAB quarterly cash flow from investing activities is $2.09 million

Quarterly CFO

$308.77 M
GMAB quarterly cash flow from operations is $308.77 million

Quarterly FCF

$301.53 M
GMAB quarterly free cash flow is $301.53 million

Quarterly CAPEX

$7.24 M
GMAB quarterly capital expenditures is $7.24 million

TTM CFF

-$580.69 M
-$54.71 M-10.40%

September 1, 2024

Summary

Performance

3-Month Change

-10.4%

1-Year Change

-700.06%

3-Year Change

-205.13%

5-Year Change

-205.13%

GMAB TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.12%
GMAB TTM cash flow from financing activities is higher than 4.12% of companies in Healthcare sector

High & Low

All-time High

$552.68 M
GMAB TTM cash flow from financing activities is currently -205.07% below its historical high of $552.68 million

3-Year Low

-$580.69 M
GMAB TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GMAB previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 8, 2025
GMAB next earnings announcement is scheduled for May 8, 2025

OtherGMABcash flowmetrics:

TTM CFI

-$1.54 B
GMAB TTM cash flow from investing activities is -$1.54 billion

TTM CFO

$983.47 M
GMAB TTM cash flow from operations is $983.47 million

TTM FCF

$958.82 M
GMAB TTM free cash flow is $958.82 million

TTM CAPEX

$24.64 M
GMAB TTM capital expenditures is $24.64 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GMAB Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.3%-1827.7%-700.1%
3 y3 years-908.8%+41.3%-205.1%
5 y5 years-682.3%+41.3%-205.1%

GMAB Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-31.6%+21.3%-507.1%+88.2%-1710.1%at low
5 y5-year-116.0%+21.3%-507.1%+88.2%-205.1%at low
alltimeall time-116.0%+21.3%-109.5%+88.2%-205.1%at low

Genmab A/S Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$51.71 M(-88.2%)
-$580.69 M(+10.4%)
Jun 2024
-
-$439.61 M(+407.2%)
-$525.99 M(+507.8%)
Mar 2024
-
-$86.67 M(+3110.9%)
-$86.53 M(-1.6%)
Dec 2023
-$87.98 M(-21.3%)
-$2.70 M(-190.2%)
-$87.98 M(+21.2%)
Sep 2023
-
$2.99 M(-1943.0%)
-$72.58 M(-54.7%)
Jun 2023
-
-$162.40 K(-99.8%)
-$160.33 M(-15.8%)
Mar 2023
-
-$88.11 M(-793.6%)
-$190.31 M(+70.1%)
Dec 2022
-$111.85 M(+67.4%)
$12.70 M(-115.0%)
-$111.85 M(-8.5%)
Sep 2022
-
-$84.75 M(+181.2%)
-$122.26 M(+281.1%)
Jun 2022
-
-$30.14 M(+212.2%)
-$32.08 M(-21.4%)
Mar 2022
-
-$9.65 M(-521.1%)
-$40.82 M(-38.9%)
Dec 2021
-$66.83 M(-714.3%)
$2.29 M(-57.7%)
-$66.83 M(+4.1%)
Sep 2021
-
$5.42 M(-114.0%)
-$64.21 M(-3.4%)
Jun 2021
-
-$38.88 M(+9.0%)
-$66.48 M(+146.2%)
Mar 2021
-
-$35.66 M(-826.5%)
-$27.00 M(-348.2%)
Dec 2020
$10.88 M(-98.0%)
$4.91 M(+55.2%)
$10.88 M(+1.4%)
Sep 2020
-
$3.16 M(+434.8%)
$10.73 M(-98.0%)
Jun 2020
-
$591.50 K(-73.3%)
$549.19 M(-0.6%)
Mar 2020
-
$2.21 M(-53.5%)
$552.68 M(+0.7%)
Dec 2019
$548.79 M(-4979.5%)
$4.76 M(-99.1%)
$548.79 M(+0.9%)
Sep 2019
-
$541.62 M(>+9900.0%)
$544.11 M(>+9900.0%)
Jun 2019
-
$4.08 M(-343.8%)
$4.86 M(-40.5%)
Mar 2019
-
-$1.67 M(-2297.0%)
$8.17 M(-172.6%)
Dec 2018
-$11.25 M(-134.4%)
$76.20 K(-96.8%)
-$11.25 M(-2.2%)
Sep 2018
-
$2.38 M(-67.8%)
-$11.50 M(+19.5%)
Jun 2018
-
$7.39 M(-135.0%)
-$9.62 M(+204.6%)
Mar 2018
-
-$21.09 M(>+9900.0%)
-$3.16 M(-109.7%)
Dec 2017
$32.73 M(+141.5%)
-$181.60 K(-104.3%)
$32.73 M(-10.6%)
Sep 2017
-
$4.26 M(-69.3%)
$36.63 M(+23.0%)
Jun 2017
-
$13.85 M(-6.4%)
$29.77 M(+31.3%)
Mar 2017
-
$14.80 M(+298.0%)
$22.67 M(+67.3%)
Dec 2016
$13.55 M(-85.8%)
$3.72 M(-243.3%)
$13.55 M(-17.4%)
Sep 2016
-
-$2.59 M(-138.4%)
$16.41 M(-56.1%)
Jun 2016
-
$6.76 M(+19.0%)
$37.41 M(-29.8%)
Mar 2016
-
$5.67 M(-13.7%)
$53.32 M(-44.3%)
DateAnnualQuarterlyTTM
Dec 2015
$95.67 M(-48.2%)
$6.58 M(-64.2%)
$95.67 M(+2.6%)
Sep 2015
-
$18.40 M(-18.8%)
$93.24 M(+31.0%)
Jun 2015
-
$22.66 M(-52.8%)
$71.19 M(+43.5%)
Mar 2015
-
$48.03 M(+1058.1%)
$49.63 M(-73.1%)
Dec 2014
$184.67 M(+583.8%)
$4.15 M(-213.7%)
$184.67 M(-5.2%)
Sep 2014
-
-$3.65 M(-432.3%)
$194.81 M(-2.8%)
Jun 2014
-
$1.10 M(-99.4%)
$200.46 M(-2.2%)
Mar 2014
-
$183.07 M(+1181.3%)
$205.03 M(+659.2%)
Dec 2013
$27.01 M(-56.3%)
$14.29 M(+610.8%)
$27.01 M(-64.1%)
Sep 2013
-
$2.01 M(-64.5%)
$75.26 M(+3.0%)
Jun 2013
-
$5.66 M(+12.2%)
$73.04 M(+8.8%)
Mar 2013
-
$5.04 M(-91.9%)
$67.11 M(+8.6%)
Dec 2012
$61.79 M(-5530.8%)
$62.54 M(<-9900.0%)
$61.79 M(-6143.2%)
Sep 2012
-
-$206.00 K(-24.0%)
-$1.02 M(-6.6%)
Jun 2012
-
-$271.00 K(-0.1%)
-$1.09 M(-3.0%)
Mar 2012
-
-$271.40 K(-1.0%)
-$1.13 M(-0.8%)
Dec 2011
-$1.14 M(-8.8%)
-$274.10 K(-1.5%)
-$1.14 M(-4.7%)
Sep 2011
-
-$278.30 K(-8.6%)
-$1.19 M(-2.0%)
Jun 2011
-
-$304.60 K(+8.4%)
-$1.22 M(+3.4%)
Mar 2011
-
-$280.90 K(-14.9%)
-$1.18 M(-5.6%)
Dec 2010
-$1.25 M(+0.3%)
-$329.90 K(+8.9%)
-$1.25 M(-1.7%)
Sep 2010
-
-$302.90 K(+14.7%)
-$1.27 M(-8.1%)
Jun 2010
-
-$264.00 K(-24.6%)
-$1.38 M(-8.7%)
Mar 2010
-
-$350.30 K(-0.3%)
-$1.51 M(+21.5%)
Dec 2009
-$1.24 M(-125.0%)
-$351.40 K(-15.2%)
-$1.24 M(+39.4%)
Sep 2009
-
-$414.30 K(+4.9%)
-$891.90 K(+86.7%)
Jun 2009
-
-$394.90 K(+377.5%)
-$477.60 K(+477.5%)
Mar 2009
-
-$82.70 K
-$82.70 K
Dec 2008
$4.98 M(-98.3%)
-
-
Dec 2007
$286.92 M(+93.8%)
-
-
Dec 2006
$148.05 M(+198.1%)
-
-
Dec 2005
$49.67 M(-41.0%)
-
-
Dec 2004
$84.20 M(<-9900.0%)
-
-
Dec 2003
-$543.60 K(-102.7%)
-
-
Dec 2002
$19.96 M
-
-

FAQ

  • What is Genmab A/S annual cash flow from financing activities?
  • What is the all time high annual CFF for Genmab A/S?
  • What is Genmab A/S annual CFF year-on-year change?
  • What is Genmab A/S quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Genmab A/S?
  • What is Genmab A/S quarterly CFF year-on-year change?
  • What is Genmab A/S TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Genmab A/S?
  • What is Genmab A/S TTM CFF year-on-year change?

What is Genmab A/S annual cash flow from financing activities?

The current annual CFF of GMAB is -$87.98 M

What is the all time high annual CFF for Genmab A/S?

Genmab A/S all-time high annual cash flow from financing activities is $548.79 M

What is Genmab A/S annual CFF year-on-year change?

Over the past year, GMAB annual cash flow from financing activities has changed by +$23.87 M (+21.34%)

What is Genmab A/S quarterly cash flow from financing activities?

The current quarterly CFF of GMAB is -$51.71 M

What is the all time high quarterly CFF for Genmab A/S?

Genmab A/S all-time high quarterly cash flow from financing activities is $541.62 M

What is Genmab A/S quarterly CFF year-on-year change?

Over the past year, GMAB quarterly cash flow from financing activities has changed by -$54.71 M (-1827.72%)

What is Genmab A/S TTM cash flow from financing activities?

The current TTM CFF of GMAB is -$580.69 M

What is the all time high TTM CFF for Genmab A/S?

Genmab A/S all-time high TTM cash flow from financing activities is $552.68 M

What is Genmab A/S TTM CFF year-on-year change?

Over the past year, GMAB TTM cash flow from financing activities has changed by -$508.11 M (-700.06%)